ZYBERNO
Stock Report
Updated Sep 1, 2026

STABLECOIN DEVELOPMENT CORPORATION (SDEV)

Healthcare • NYSE

$0.95

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
38.0/100
WEAK BUSINESS
STABLECOIN DEVELOPMENT CORPORATION (SDEV) scores 38/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
Margin of Safety unavailable — insufficient data for the owner-earnings DCF.
Is the market underestimating or overestimating what this business is capable of going forward?
+19.0%
Market Underestimates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-98.4%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.01x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):NEUTRAL (311.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

STABLECOIN DEVELOPMENT CORPORATION (SDEV) stock report — Zyberno Score 38/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

According to Zyberno's DCF model, STABLECOIN DEVELOPMENT CORPORATION (SDEV) shows a Brina Gap of +19.0%, which strengthens the case: based on the company's ROIC (311.0%) and reinvestment rate (-0.3%), the business can fundamentally grow at -1.0% — but the current enterprise value implies the market expects -20.0%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.95
Market Cap:$29.35M

Valuation Multiples (4)

P/B Ratio:0.23x
P/S Ratio:3.00x
Peg Ratio:0.00x

Enterprise Metrics (2)

Enterprise Value:$22.38M
Ev Ebitda Ratio:0.04x
B. Profitability Assessment

Return Metrics (7)

ROA:-156.6%
Reinvestment Rate:-0.3%
Fundamental Growth Rate (g):-1.0%
Market-Implied Growth Rate:-20.0%

Margin Analysis (1)

Ebitda Margin:5,102.1%

Yield Metrics (2)

Earnings Yield:$141.75
Dividend Yield:15.1%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:86.2%
Latest Earnings Filed:2026-07-30

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-17.1%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:29.98x
Quick Ratio:28.25x
Cash Ratio:25.81x

Leverage Analysis (3)

Debt To Equity Ttm:0.01x
Debt-to-Equity Ratio:0.01x
Debt To Ebitda:0.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,825,000.00
Cash And Cash Equivalents:6,968,000.00
Long Term Debt:$0.00
Net Debt:-$6.97M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $9.78M
Linear Growth: -17.1%
📊 Click to view full SDEV Revenue analysis & methodology →
Cost Of Revenue Ttm:$3.30M

Profitability Breakdown (2)

Gross profit TTM: $6.48M
Linear Growth: -29.6%
📊 Click to view full SDEV Gross Profit analysis & methodology →
$498.76M

Bottom Line Performance (3)

-$125.20M
Income Before Tax:$505.44M
Ebitda Ttm:499,033,000.00

Operating Expenses (5)

Operating Expenses:11,523,000.00
R And D Expense:42,000.00
Sga Expense:11,258,000.00
Income Tax Expense:-$428.00K
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:1.9%
Sga To Revenue Percentage:510.3%
Ebitda Margin:5,102.1%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$127.51M
Current Assets:$8.10M
Ppe Net:404,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:270,000.00
Current Liabilities:270,000.00
Long Term Debt:$0.00
Short Term Debt:$0.00

Equity & Capital (3)

Equity:$127.24M
Retained Earnings:-$307.72M
Common Stock:5,000,000,000.00

Working Capital Items (3)

Accounts Receivable:704,000.00
Inventory:467,000.00
Accounts Payable:270,000.00

Special Items (2)

Contract Liabilities:751,000.00
Stock Based Compensation:11,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$8.91M-$8.91M

Investment Activities (2)

Investing Cash Flow:-$25.92M
Capital Expenditures Ttm:4,000.00

Financing Activities (3)

Financing Cash Flow:$38.34M
Dividends Paid Ttm:4,815,000.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:278,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-89.59
$1.46
Earnings Per Share Ttm:-$4.03

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.32
Operating Cash Flow Per Share:-$0.24

Book Value & Capital (2)

Book Value Per Share:$4.10
Cash Per Share:0.22

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.12x
Working Capital Turnover Ttm:1.25x

Receivables Management (2)

Receivables Turnover Ttm:13.89x
Days Sales Outstanding Ttm:26.27

Inventory Management (2)

Inventory Turnover Ttm:7.07x
Days Inventory Outstanding Ttm:51.65

Payables & Cash Cycle (2)

Days Payable Outstanding:29.86
Cash Conversion Cycle:48.06
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (4)

Reinvestment Rate:-0.3%
Fundamental Growth Rate (g):-1.0%
Market-Implied Growth Rate:-20.0%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-17.1%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-29.6%
Book Value Growth Rate (Linear):14.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:SDEV
Company Name:STABLECOIN DEVELOPMENT CORPORATION
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:31.05M
Shares Outstanding Basic:31.05M
Shares Outstanding Diluted:31.05M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 08:59:19 UTC
Data Timestamp:2026-08-20T22:35:16.970015
Scroll to Top